| Stage | CNR | % of rev | HCC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $510M | 100.00% | CNR ×2.24 |
| Gross profit | $252M | 22.09% | $163M | 31.90% | HCC +9.8pp |
| Operating income | $156M | 13.65% | $95M | 18.54% | HCC +4.9pp |
| Pre-tax income | $143M | 12.53% | $91M | 17.88% | HCC +5.4pp |
| Net income | $126M | 11.08% | $87M | 17.15% | HCC +6.1pp |
| Stage | CNR | HCC | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $510M100.00% | CNR ×2.24 |
| Gross profit | 22.09%$252M | 31.90%$163M | HCC +9.8pp |
| Operating income | 13.65%$156M | 18.54%$95M | HCC +4.9pp |
| Pre-tax income | 12.53%$143M | 17.88%$91M | HCC +5.4pp |
| Net income |
| 11.08%$126M |
| 17.15%$87M |
| HCC +6.1pp |
No disclosed counterparties: CNR, HCC.